Key result
Two Tryton sidebranch stents and a single DES successfully treat a double coronary bifurcation lesion.
Why the study?
The optimal percutaneous treatment strategy for coronary bifurcation lesions remains unknown despite development of dedicated bifurcation stents.
Case Report (n=1)
This case report demonstrates the technical feasibility of treating a double coronary bifurcation lesion with two Tryton sidebranch stents and a single main vessel drug-eluting stent.
This strategy appears technically feasible in double bifurcation lesions; leaves open long-term safety and efficacy data.
The optimal percutaneous treatment strategy for coronary bifurcation lesions is still unknown. Several dedicated coronary bifurcation stents, such as the Tryton Side Branch Stent™ (Tryton Medical, Durham, NC) have been developed to improve clinical outcomes. We presented a double bifurcation lesion case treated with two Tryton sidebranch stents, with a single drug eluting stent covering the main vessel and both bifurcations.
No takes yet. Share an insight, caveat, or question.
Unzué et al. (2013) conducted a case report in Double coronary bifurcation lesion (n=1). Two Tryton sidebranch stents and a single drug-eluting stent was evaluated. A double coronary bifurcation lesion was treated using two Tryton sidebranch stents and a single drug-eluting stent covering the main vessel and both bifurcations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: